neue hoffnung bei UNIVERSAL DETECTION TECH - 500 Beiträge pro Seite

[luckier]

Symbol: UDTT
http://www.udetection.com/pressroom-video-NBC1006.htm

[novem]

Antwort auf Beitrag Nr.: 29.279.076 von luckier am 12.05.07 10:25:03

Hallo, luckier.

Sei doch bitte so nett und klär mich mal auf, was die neue Hoffnung begründet, da mein Englisch sehr mäßig ist. Über gute Nachrichten wäre ich hier natürlich sehr erfreut.

Danke und Gruß,
novem

[luckier]

Antwort auf Beitrag Nr.: 29.279.900 von novem am 12.05.07 13:00:24

in kürze
was ich damit meine ist der letzte report in dem festgestellt wurde
das bei einem anthraxangriff nicht genügend schutz vorhanden sei,
die abteilung der homeland security die dafür verantwortlich ist
könnte bei einem angriff mit anthrax, mit den zur zeit verfügbaren mitteln die sie einsetzt nicht sicherstellen das z. B. ein
Gebäude frei von sporen ist.

[luckier]

hier der orginal text dazu
http://biz.yahoo.com/iw/070510/0250899.html

[novem]

Antwort auf Beitrag Nr.: 29.280.046 von luckier am 12.05.07 13:32:58

Guten Morgen, luckier.

Habe den Text mal übersetzen lassen (auch wenn die Programme, naja, sagen wir mal mäßig sind - besser als nichts) und wenn ich das richtig interpretiere, hat Universal Detection laut einem Bericht vom 10.05.07 von ihrem Spürgerät BSM-2000 zwei Einheiten an Großbritannien verkauft. Des weiteren ist ja dann wohl auch ein Heimatsicherheitsausschuß im Reprasetantenhaus gebildet worden, wo Universal Detection die Mitarbeiter schulen soll. Korregier mich bitte, wenn ich falsch liege.

Aber das würde ich doch als gute News einstufen und wenn dem denn so sein sollte, müsste das doch positive Auswirkungen auf den Kurs haben. Gerade dann, wenn ich bedenke, das so manche OTC-Bude offenbar nur von Luft und Liebe lebt und die Kurse trotzdem nach Norden gehen, so müsste hierdurch doch auch ein Schub erfolgen, denn das klingt doch eher nach substanziellen News und nicht nach Durchhalteparolen.

Habe das allerdings noch nicht auf deren Homepage gefunden, aber wäre es nicht angebracht, das zu veröffentlichen?

Wie siehst du das Ganze?

Gruß,
novem

[miss29]

May 15, 2007 - 7:05 AM EDT

close Email this News Article
Your Name
Your Email
Friend's Name
Friend's Email
Receive Copy: yes

UDTT 0.0035 0.00

Today 5d 1m 3m 1y 5y 10y



Universal Detection Technology Features "Air Monitoring Series" DVD Set on E-Commerce Store
Universal Detection Technology (www.udetection.com) (OTCBB: UDTT) -- a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, has added a new DVD set to the Company's e-commerce store.

The new film set is called "Air Monitoring Series." This two-tape series studies basic monitoring instruments and sampling procedures used in emergency response. It is designed to provide training to emergency responders who carry out atmospheric sampling activities when a hazardous materials incident occurs. This program was created with the assistance of major instrument manufacturers and is the most comprehensive program available on the subject of air monitoring.

The Company was recently featured on NBC News in a piece that can be viewed at http://www.udetection.com/pressroom-video-NBC1006.htm." target="_blank" rel="nofollow ugc noopener">http://www.udetection.com/pressroom-video-NBC1006.htm.

For more information please email us at [e-mail] or visit our website at www.udetection.com.

About Emergency Film Group

Emergency Film Group is the award-winning leader in video and DVD-based training for hazmat & terrorism emergency response. Since 1987, Emergency Film Group has produced and distributed award-winning training films, videos and DVDs of interest to the hazardous materials, counterterrorism, environmental and emergency response communities in both the public and the private sector.

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bio-terrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain biohazard substances. For more information, please visit: http://www.udetection.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact:
Universal Detection Technology
Jacques Tizabi
310-248-3655
Email Contact





Source: Market Wire (May 15, 2007 - 7:05 AM EDT)

[Saftladen]

bid 0,004

ask 0,0045

[miss29]

Antwort auf Beitrag Nr.: 29.325.797 von Saftladen am 15.05.07 15:11:27

[miss29]

Antwort auf Beitrag Nr.: 29.326.177 von miss29 am 15.05.07 15:30:49

GO BABY ! Ich will 2000%

[luckier]

so jetzt gibts kein halten mehr

Universal Detection Receives Purchase Order for One Hundred Anthrax Test Kits From Dubai-Based, Gulf Security Solutions
UDTT to Make First Sale of Anthrax Detection Kits in the United Arab Emirates
Universal Detection Technology (www.udetection.com) (OTCBB: UDTT), a developer of early-warning monitoring technologies to protect people from bioterrorism and a provider of counter terrorism training and solutions, announced today that it received a purchase order for one hundred Anthrax Test Kits from Gulf Security Solutions in Dubai.

\"This is a major milestone for our company as we begin marketing our counterterrorism solutions in the Middle East and Persian Gulf area,\" said Jacques Tizabi, CEO of Universal Detection Technology. \"This is obviously a region in the world where security is of great concern and we are excited to have our first sale of bio-warfare detection kits there,\" he added.

[Saftladen]

Universalabfragung empfängt Kaufauftrag für hundert Anthrax-Test-Installationssätze von Dubai-Gegründet, Golf-Sicherheit Lösungen UDTT, zum des ersten Verkaufes von den Anthrax-Abfragung Installationssätzen in den vereinigten arabischen Emiräten zu bilden Universalabfragung Technologie (www.udetection.com) (OTCBB: UDTT), ein Entwickler der Frühwarnüberwachentechnologien, zum der Leute vor bioterrorism und des Versorgers des Gegenterrorismustrainings und -lösungen zu schützen, heute verkündet, daß er einen Kaufauftrag für hundert Anthrax-Test-Installationssätze von den Golf-Sicherheit Lösungen in Dubai empfing. \ „dieses ist hauptsächlich Meilenstein für unser Firma, da wir Marketing unsere counterterrorism Lösungen im Bereich des Mittlere Ostens und des persischen Golfs anfangen, \“ sagte Jacques Tizabi, CEO der Universalabfragung Technologie. \ „dieses ist offensichtlich Region in Welt, in der Sicherheit von großem Belang ist und wir aufgeregt werden, um unseren ersten Verkauf von, der Bio-kriegsführung Abfragung Installationssätze dort, \“ zu haben fügte er hinzu.

[miss29]

Antwort auf Beitrag Nr.: 29.351.503 von Saftladen am 16.05.07 22:31:20

JETZT GEHT LOS !!!!!!!!!!!!!

Ist morgen handel in Deutschland ?

[luckier]

bin mal gespannt auf die ersten kurse

[miss29]

Antwort auf Beitrag Nr.: 29.356.646 von luckier am 17.05.07 13:44:31

Hier sind so viele Short.
Sollte es schnell nach oben gehen, dann knallt es gewaltig!

[miss29]

Antwort auf Beitrag Nr.: 29.356.739 von miss29 am 17.05.07 13:51:40

BID/ASK geht jetzt schon UP

[luckier]

Antwort auf Beitrag Nr.: 29.356.739 von miss29 am 17.05.07 13:51:40

wie wäre es mit einem kleinen tip spiel
eröffnung und schlusskurs
als hätte man nichts besseres zu tun am vatertag
aber bin noch am warten bis meine große (tochter) eintrifft

[luckier]

Antwort auf Beitrag Nr.: 29.356.868 von miss29 am 17.05.07 14:01:32

sollte NITE aber auch auf der bid seite nachziehen

[miss29]

Antwort auf Beitrag Nr.: 29.356.881 von luckier am 17.05.07 14:02:28

Ich Tippe an der OTC jetzt nichts mehr

Hier ist alles Möglich: Chapter-11 Firmen machen 2000% an einem Tag und Profitable Firmen gehen Monate lang in den Keller

[miss29]

Antwort auf Beitrag Nr.: 29.356.917 von luckier am 17.05.07 14:05:53

Machen sie auch, kurz vor 15:30

[luckier]

Antwort auf Beitrag Nr.: 29.356.952 von miss29 am 17.05.07 14:09:13

OTC ist halt so, es wird auch immer welche geben die
denken auf die schnelle den großen reibach machen zu können.
hier ist alles möglich, man sollte eben nur mit
spielgeld investieren das man verkraften kann.

[miss29]

08:28 Close
Knight Equity Markets, L.P.

NITE 5000 0.004

[luckier]

Antwort auf Beitrag Nr.: 29.357.458 von miss29 am 17.05.07 14:50:02

jo, und jetzt noch ARCA auf der bid seite dann kanns abgehen

[luckier]

die ersten 500000 sind schon wech

[miss29]

Antwort auf Beitrag Nr.: 29.357.682 von luckier am 17.05.07 15:10:41

Wo kann ich es sehen ?

[luckier]

Antwort auf Beitrag Nr.: 29.357.707 von miss29 am 17.05.07 15:12:48

http://www.wallstreet-online.de/informer/community/thread.ht…

[miss29]

[luckier]

Antwort auf Beitrag Nr.: 29.357.927 von miss29 am 17.05.07 15:31:31

mein IE spinnt, wahrscheinlich ist der cache voll, oder ich habe schon ein paar biere zuviel

[miss29]

Antwort auf Beitrag Nr.: 29.357.942 von luckier am 17.05.07 15:32:57

.0047$

[luckier]

Antwort auf Beitrag Nr.: 29.357.953 von miss29 am 17.05.07 15:33:42

danke

[miss29]

Jetzt wird gekauft 600k

[miss29]

Gap zu, go Baby !

[luckier]

Antwort auf Beitrag Nr.: 29.358.545 von miss29 am 17.05.07 16:09:20

ich glaub ich fahr mal ne kleine attacke

[miss29]

Antwort auf Beitrag Nr.: 29.358.685 von luckier am 17.05.07 16:16:32

Dann los

[miss29]

Antwort auf Beitrag Nr.: 29.358.685 von luckier am 17.05.07 16:16:32

Was ist mit den AMIS los ?

[luckier]

Antwort auf Beitrag Nr.: 29.358.989 von miss29 am 17.05.07 16:30:12

OTC, hab ich die vorher geschrieben, jeder will jetzt noch billig rein

[miss29]

Antwort auf Beitrag Nr.: 29.359.074 von luckier am 17.05.07 16:33:53

Oder raus

[luckier]

Antwort auf Beitrag Nr.: 29.359.188 von miss29 am 17.05.07 16:38:50

abwarten heute ist der cent angesagt

[luckier]

bin jetzt am anschlag mehr kann ich nicht mehr kaufen

[luckier]

#miss29
kannst du bitte den rt nochmals reinstellen.
irgendwas spinnt bei den anzeigen die ich hier bekomme
hab schon die fw ausgeschaltet, bringt alles nichts

[luckier]

attacke

[miss29]

Antwort auf Beitrag Nr.: 29.362.418 von luckier am 17.05.07 19:37:57

Bin wieder da

Sag mal, können die AMIS überhaupt lesen

[miss29]

Universal Detection Receives Purchase Order for One Hundred Anthrax Test Kits From Dubai Based, Gulf Security Solutions

und der Chart dazu:

[opelmanta3]

in den nächstem paar tagen kommt die 10Q raus...

[luckier]

morgn
Future Bulls WTVI, ACEN, UDTT

[luckier]

http://ragingbull.quote.com/mboard/boards.cgi?board=UDTT&rea…

[opelmanta3]

PART I
FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

UNIVERSAL DETECTION TECHNOLOGY AND SUBSIDIARIES

UNAUDITED CONSOLIDATED BALANCE SHEET
MARCH 31, 2007


ASSETS

CURRENT ASSETS:
Cash and cash equivalents .................................. $ 30,557
Certificates of deposit .................................... 11,027
Accounts Receivable, net ................................... 250
Prepaid expenses and other current assets .................. 6,084
------------

Total current assets ....................................... 47,918

DEPOSITS ................................................... 10,226
EQUIPMENT, NET ............................................. 76,219
PATENT COSTS ............................................... 117,341
------------

$ 251,704
============


LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES:
Accounts payable, trade .................................... $ 699,318
Bank overdraft ............................................. 3,837
Accrued liabilities ........................................ 812,664
Notes payable - related party .............................. 2,500
Notes payable .............................................. 1,110,564
Accrued interest expense ................................... 394,221
------------

Total current liabilities .................................. 3,023,104

Note Payable Long term, net of current portion ............. 14,443
------------

Total Liabilities .......................................... 3,037,547
------------

COMMITMENTS AND CONTINGENCIES .............................. --

STOCKHOLDERS' EQUITY (DEFICIT):
Preferred stock, $.01 par value, 20,000,000
shares authorized

Series A-1, 150 shares issued and outstanding .............. 1
Common stock, no par value, 480,000,000 shares
authorized, 331,133,726 shares issued and
outstanding .............................................. 26,270,617
Additional paid-in-capital ................................. 5,363,088
Accumulated (deficit) ...................................... (34,419,549)
------------

Total stockholders' equity (deficit) ....................... (2,785,843)
------------

Total Liabilities and Stockholders Equity (deficit) ........ $ 251,704
============

See accompanying notes to unaudited consolidated financial statements.


2





UNIVERSAL DETECTION TECHNOLOGY AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS


For the three months ended
March 31,
------------------------------
2007 2006
------------- -------------

REVENUE ............................................ $ 1,175 $ --
COST OF GOODS SOLD ................................. 1,650 --
------------- -------------

GROSS PROFIT (LOSS) ................................ (475) --
------------- -------------

OPERATING EXPENSES:
Selling, general and administrative ................ 1,616,918 636,172
Marketing .......................................... 15,000 101,300
Research and development ........................... -- 8,250
Depreciation ....................................... 6,182 6,182
------------- -------------

Total expenses ..................................... 1,638,100 751,904
------------- -------------

(LOSS) FROM OPERATIONS ............................. (1,638,575) (751,904)

OTHER INCOME (EXPENSE):
Interest income .................................... 663 4
Interest expense ................................... (42,247) (57,585)
Amortization of loan fees .......................... -- (16,926)
------------- -------------


Net other income (expense) ......................... (41,584) (74,507)
------------- -------------

(LOSS) FROM OPERATIONS BEFORE INCOME TAXES ......... (1,680,159) (826,411)

INCOME TAX EXPENSE ................................. -- --
------------- -------------

NET (LOSS) ......................................... $ (1,680,159) $ (826,411)
============= =============

NET INCOME (LOSS) PER SHARE - BASIC AND DILUTED: ... $ (0.006) $ (0.014)
============= =============

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING 273,535,590 58,322,418
============= =============


See accompanying notes to unaudited consolidated financial statements.


3





UNIVERSAL DETECTION TECHNOLOGY AND SUBSIDIARIES

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS


For the three months ended
March 31,
--------------------------
2007 2006
----------- -----------

CASH FLOWS FROM (TO) OPERATING ACTIVITIES:
Net (loss) .............................................. $(1,680,159) $ (826,411)
Adjustments to reconcile net (loss) to net cash (used in)
operations:
Stocks and warrants issued for services ................. 1,302,244 221,166
Depreciation ............................................ 6,182 6,182
Changes in operating assets and liabilities:
Inventory, Installation in process ...................... -- (2,566)
Accounts receivable ..................................... (250) (55,507)
Prepaid expenses ........................................ 31,887 208,115
Deferred revenue ........................................ -- 55,507
Accounts payable and accrued expenses ................... 36,380 130,633
----------- -----------

Net cash (used in) operating activities ................. (303,716) (262,881)
----------- -----------
CASH FLOWS (TO) FROM INVESTING ACTIVITIES:

Decrease in restricted cash ............................. 51,280 20,000
----------- -----------

Net cash provided by investing activities ............... 51,280 20,000
----------- -----------
CASH FLOWS FROM (TO) FINANCING ACTIVITIES:
Bank overdraft .......................................... 3,837 (1,113)
Proceeds from sale of common stock ...................... 21,000 125,000
Proceeds from exercise of warrants ...................... -- 221,500
Advances from related party ............................. 28,000 --
Advances on notes payable ............................... 300,000 --
Payments on Capital Lease ............................... -- (2,491)
Payments on notes payable - related party ............... (28,000) (54,312)
Payments on notes payable ............................... (59,957) (37,600)
----------- -----------

Net cash provided by (used in) financing activities ..... 264,880 250,984
----------- -----------


NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS .... 12,444 8,103

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD .......... 18,113 13,248
----------- -----------

CASH AND CASH EQUIVALENTS, END OF PERIOD ................ $ 30,557 $ 21,351
=========== ===========

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:

Interest Paid ........................................... $ 34,989 $ 8,878
=========== ===========


See accompanying notes to unaudited consolidated financial statements.


4




UNIVERSAL DETECTION TECHNOLOGY AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2007


NOTE 1 - BASIS OF PRESENTATION

The accompanying unaudited consolidated financial statements have been prepared
in accordance with accounting principles generally accepted in the United States
of America for interim financial information and with the instructions to Form
10-QSB and Item 310 of Regulation S-B. Accordingly, they do not include all of
the information and footnotes required by generally accepted accounting
principles for complete financial statements. The accompanying unaudited
consolidated financial statements reflect all adjustments that, in the opinion
of management, are considered necessary for a fair presentation of the financial
position, results of operations, and cash flows for the periods presented. The
results of operations for such periods are not necessarily indicative of the
results expected for the full fiscal year or for any future period. The
accompanying financial statements should be read in conjunction with the audited
consolidated financial statements of Universal Detection Technology included in
Form 10-KSB for the fiscal year ended December 31, 2006.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

MANAGEMENT PLANS AND GOING CONCERN

As of March 31, 2007, the Company had a working capital deficit of $2,975,186
and an accumulated deficit of $34,419,549. These conditions raise substantial
doubt about its ability to continue as a going concern. Its ability to continue
as a going concern is dependent upon its ability to develop additional sources
of capital and ultimately achieve profitable operations. The financial
statements do not include any adjustments that might result from the outcome of
this uncertainty. The Company's financial statements have been presented on the
basis that it is a going concern, which contemplates the realization of assets
and the satisfaction of liabilities in the normal course of business.

The Company is currently devoting its effort to raising capital, and to the
development, field-testing and marketing of its bio-terrorism detection device,
known as BSM-2000 and to the expansion of its product line into other
counterterrorism products and services in related fields including threat
evaluation services, safety videos, and anthrax detection kits. . During the
first quarter of 2007, the Company shipped anthrax detection kits under various
purchase agreements for proceeds of $1,150.

The Company entered into a technology affiliates agreement and a license
agreement with NASA's JPL and Caltech. The Company unveiled the first functional
prototype of its BSM-2000 in May 2004. Although the Company continues to engage
in testing of BSM-2000 to improve its functionality, BSM-2000 is currently
available for sale. During 2006, the Company sold two units the BSM-2000 Anthrax
Detection Systems to the government of the United Kingdom. The Company shipped
both units and payment for both has been received and the Company has no further
obligations under the sales agreement.

In February 2006, the Company entered into a marketing and sales agreement with
Security Solutions International (SSI), pursuant to which SSI will market
BSM-2000 in the United States. The Company maintains close relationships with
SSI and hopes to collaborate on more training or marketing projects with them in
the future. In January and February of 2007 the Company received two purchase
orders from SSI for one and five units of our anthrax test kits respectively.
The company also participated in training various members of law enforcement in
Washington DC in April 2007 with SSI, on dealing with biological threats.

During the three months ended March 31, 2007, 33,337,129 shares were sold
pursuant to a prior investment agreement for $146,500. The Company received
$21,000 cash and the remaining $125,500 was paid directly to note holders for
repayment of outstanding notes payable and accrued interest. The Company will no
longer be using the investment agreement to raise funds.


5




UNIVERSAL DETECTION TECHNOLOGY AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2007


In January 2007, the Company entered into an agreement to sell 60,000,000 shares
of its common to a third party for $1,800,000 cash equivalent credits. The cash
equivalent credits may be used in combination with cash to obtain certain goods
and services. The value of the stock issued in consideration for the credits was
$288,000. While management believes that it will be able to utilize the credit
to purchase goods or services to be used in the operations of the Company, it
must raise additional debt or equity financing in order to combine the credits
with cash consideration. Management continually evaluates its ability to utilize
the cash equivalent credits and has elected to carry the credits at $0 on its
future balance sheets. The Company continues to evaluate uses for such credits.

SIGNIFICANT ACCOUNTING POLICIES

For a description of the Company's significant accounting policies, refer to the
notes to the audited consolidated financial statements for the Company for its
year ended December 31, 2006 included in the Company's Annual Report on Form
10-KSB for that year, as it may be amended.

RECLASSIFICATION

Certain reclassifications have been made to the balances as of March 31, 2006 to
conform to the March 31, 2007 presentation.

REVENUE RECOGNITION

Revenue is recognized upon satisfaction of the Company's obligations, generally
upon shipment and acceptance of products and devices have occurred. Title of
goods is generally transferred when the products are shipped from the Company's
facility. Income not earned will be recorded as deferred revenue. Service
revenue, including event security, is recognized when services are performed.

STOCK-BASED COMPENSATION

The Company adopted SFAS No. 123 (Revised 2004), SHARE BASED PAYMENT ("SFAS No.
123R"), under the modified-prospective transition method on January 1, 2006.
SFAS No. 123R requires companies to measure and recognize the cost of employee
services received in exchange for an award of equity instruments based on the
grant-date fair value. Share-based compensation recognized under the
modified-prospective transition method of SFAS No. 123R includes share-based
compensation based on the grant-date fair value determined in accordance with
the original provisions of SFAS No. 123, ACCOUNTING FOR STOCK-BASED
COMPENSATION, for all share-based payments granted prior to and not yet vested
as of January 1, 2006 and share-based compensation based on the grant-date
fair-value determined in accordance with SFAS No. 123R for all share-based
payments granted after January 1, 2006. SFAS No. 123R eliminates the ability to
account for the award of these instruments under the intrinsic value method
prescribed by Accounting Principles Board ("APB") Opinion No. 25, ACCOUNTING FOR
STOCK ISSUED TO EMPLOYEES, and allowed under the original provisions of SFAS No.
123. The Company recognized $661,484 and $0 in share-based compensation expense
for the three months ended March 31, 2007 and 2006, respectively.


6




UNIVERSAL DETECTION TECHNOLOGY AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2007


STOCK BASED COMPENSATION TO OTHER THAN EMPLOYEES

The Company accounts for equity instruments issued in exchange for the receipt
of goods or services from other than employees in accordance with Statement of
Financial Accounting Standards No. 123, "Accounting FOR STOCK-BASED
COMPENSATION," and the conclusions reached by the Emerging Issues Task Force in
Issue No. 96- 18, "Accounting for Equity Instruments That Are Issued to Other
Than Employees for Acquiring or in Conjunction with Selling Goods or Services"
("EITF 96-18"). Costs are measured at the estimated fair market value of the
consideration received or the estimated fair value of the equity instruments
issued, whichever is more reliably determinable. The value of equity instruments
issued for consideration other than employee services is determined on the
earlier of a performance commitment or completion of performance by the provider
of goods or services as defined by EITF 96-18.

EARNINGS PER SHARE

In accordance with SFAS No. 128, "EARNINGS PER SHARE," the basic loss per common
share is computed by dividing net loss available to common stockholders by the
weighted average number of common shares outstanding. Diluted loss per common
share is computed similar to basic loss per common share except that the
denominator is increased to include the number of additional common shares that
would have been outstanding if the potential common shares had been issued and
if the additional common shares were dilutive. At March 31, 2007 and March 31,
2006, the only potential dilutive securities were outstanding options and
warrants to purchase 116,937,430 and 21,341,667 shares of common stock
respectively. Due to the net loss, none of the potentially dilutive securities
were included in the calculation of diluted earnings per share since their
effect would be anti-dilutive.

INCOME TAXES

Deferred income taxes are recorded to reflect the tax consequences in future
years of temporary differences between the tax basis of the assets and
liabilities and their financial statement amounts at the end of each reporting
period. Valuation allowances are established when necessary to reduce deferred
tax assets to the amount expected to be realized. Income tax expense is the tax
payable for the current period and the change during the period in deferred tax
assets and liabilities. The deferred tax assets and liabilities have been netted
to reflect the tax impact of temporary differences. At March 31, 2007, a full
valuation allowance has been established for the deferred tax asset as
management believes that it is more likely than not that a tax benefit will not
be realized.


7




UNIVERSAL DETECTION TECHNOLOGY AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2007


USE OF ESTIMATES IN THE PREPARATION OF FINANCIAL STATEMENTS

The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
revenues and expenses during the reporting period. Actual results could differ
from those estimates.

RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

The Company has adopted all accounting pronouncements effective before March 31,
2007, which are applicable to the Company.

NOTE 3 - ACCRUED LIABILITIES

Included in accrued liabilities are payments due in connection with certain loan
fees. A total of 300,000 shares are payable to third parties. The total value of
the stock on the date of the notes was $68,600.

NOTE 4 - NOTES PAYABLE

During the first quarter of 2007, the Company borrowed an aggregate of $300,000
from third parties under various promissory note agreements. The promissory
notes all bear interest at 12.5% per annum, due on or before April 13, 2007. No
interest or principal payments have been made on the notes and have been
verbally extended.

NOTE 5 - COMMITMENTS AND CONTINGENCIES

a) A. Sean Rose, Claire F. Rose and Mark Rose v. Universal Detection
Technology, fka Pollution Research and Control Corporation Superior Court
of the State of California for the County of Los Angeles, North Central
District, Case No. EC042040

On or about April 16, 2004, Plaintiffs commenced an action against the Company
(Case No. EC 038824) for amounts allegedly due pursuant to four unpaid
promissory notes. On August 2, 2004, the parties executed a Confidential
Settlement Agreement and Mutual Releases (the "AGREEMENT"). On December 30,
2005, Plaintiffs commenced the above-referenced action against the Company,
alleging the Company breached the Agreement and seeking approximately $205,000
in damages. A judgment was entered on April 11, 2006. The Company has previously
accrued for this settlement.

b) Steven P. Sion and Sion Consulting, Inc. v. Universal Detection Technology
Corporation, et. Al. Superior Court of the State of California for the
County of Los Angeles, Case NO. BC350942

On April 19, 2006, Plaintiffs Steven P Sion and Sion Consulting, Inc., a Nevada
corporation, instituted an action in the Los Angeles Superior Court (Central
District Case


8




UNIVERSAL DETECTION TECHNOLOGY AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2007


No. BC350942) against Defendants Universal Detection Technology Corporation,
Albert E. Gooselin, Jr., Roy Peterson, Greg Edwards, Bombay Consortium, Inc.,
Howard Sperling, Assisted Care, Inc. As to Universal Detection, Plaintiffs
alleged claims for: (1) Breach of Contract; (2) Fraud, (3) Negligent
Misrepresentation; and (4) Conspiracy in relation to the sale of Dasibi
Environmental Corp. Plaintiffs seeks an unspecified amount of compensatory,
general and punitive damages against all Defendants. On July 17, 2006, Universal
Detection timely filed an Answer to the Complaint. Universal Detection strongly
disputes and shall vigorously defend against the allegations of the Complaint.
To date, no trial date has been set. While Universal Detection disputes these
allegations, the Company cannot control the outcome of the case or what damages,
if any, will result.

c) During 2005, the Company entered into two lease agreements to lease testing
equipment. The Company had violated the terms of the lease as the Company
sold the equipment in March 2006. In April 2006, the leasing company agreed
to remove the sale of equipment as a default of the lease and treat the two
leases as one single purchase transaction. Under the forebearance agreement
entered into by the two parties, the Company shall pay the outstanding
balance plus interest at a rate of 18% in monthly payments of $1,816 until
October 15, 2008. The outstanding balance on this note is $32,164 as of
March 31, 2007.

On June 2, 2006, Plaintiff Trilogy Capital Partners instituted an action in the
Los Angeles Superior Court (TRILOGY CAPITAL PARTNERS V. UNIVERSAL DETECTION
TECHNOLOGY, ET. AL., Case No. SC089929) against Defendant Universal Detection
Technology. Plaintiff's Complaint alleged damages against the Company for breach
of an engagement letter in the amount of $93,448.54. Also, Plaintiff alleged
that the plaintiff had failed to issue warrants to it pursuant to a written
agreement, which have been recorded and expensed in the December 31, 2006 and
2005 financial statements. After completing the initial stages of litigation and
conducting extensive mediation, Plaintiff and the Company reached a settlement
commencing December 15, 2006, the Company would make monthly payments to
Plaintiff of $2,000 until a debt of $90,000 plus accrued interest at six percent
per annum was fully paid. In exchange, Plaintiff would release all of its claims
against the Company. The amounts due under the agreement have previously been
accrued for in the financial statements.

On November 15, 2006, Plaintiff NBGI, Inc. instituted an action in the Los
Angeles Superior Court (NBGI, Inc. v. Universal Detection Technology, et. al.,
Case No. BC361979) against Defendant Universal Detection Technology. NBGI,
Inc.'s Complaint alleged breach of contract, and requested damages in the amount
of $111,014.34 plus interest at the legal rate and for costs of suit. The
Company strongly disputes and shall vigorously defend against the allegations of
the Complaint. To date, discovery has commenced, but no trial date has been set.
The Company has recorded the amounts due as notes payable in the financial
statements.


9




UNIVERSAL DETECTION TECHNOLOGY AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2007


From time to time, the Company is a party to a number of lawsuits arising in the
normal course of business. In the opinion of management, the resolution of these
matters will not have a material adverse effect on the Company's operations,
cash flows or financial position.

NOTE 6 - STOCKHOLDERS' EQUITY

During the three months ended March 31, 2007, the Company issued an aggregate of
12,187,496 shares of common stock to employees for services rendered to the
Company valued at $52,000.

During the three months ended March 31, 2007, the Company issued 48,000,000
shares of common stock as payment for consulting services for an aggregate
amount of $299,600.

During the three months ended March 31, 2007, an investor purchased 33,337,129
shares of common stock as required under an investment agreement for an
aggregate amount of $146,500. The Company received $21,000 of the proceeds
during the first quarter of 2007. The remaining $125,500 was used to repay
outstanding notes payable and accrued interest. The notes were paid directly by
the investor.

PREFERRED STOCK

On March 28, 2007, the Board of Directors approved the creation of the Series
A-1 Preferred Stock of the Company and the issuance of 150 shares of such stock
to Jacques Tizabi for $50,000 in accrued compensation. The stock entitles the
holder to 1,000,000 votes per share, which shall vote together with the Common
Stock of the Company for all purposes, except where a separate vote of the
classes of capital stock is required by California law. The aggregate value of
the 150 shares issued to Mr. Tizabi is $50,000. The shares have a liquidation
value, as described in the Company's Articles of Incorporation, of $50,000. Mr.
Tizabi is prohibited, by agreement with the Company, from transferring or
selling such stock, or any interest in such stock for so long as the shares are
outstanding.

During the first quarter of 2007, the Company issued to Mr. Tizabi, 100,000,000
shares of Common Stock in exchange for the cancellation of indebtedness owed to
him. However, the Company determined to cancel such issuance, and issue in lieu
thereof, the shares of Series A-1 Preferred Stock and the Option described
below. Additionally, Mr. Tizabi has contributed $550,000 of accrued compensation
to the Company. The Company has recorded $550,000 as additional paid-in capital.

STOCK OPTIONS

On March 28, 2007, the Company granted to Jacques Tizabi, its president and CEO
an option to purchase 100,000,000 shares of Common Stock at an exercise price of
$0.01 per share, for a term of five years. The option is fully vested and
immediately exercisable.


10




UNIVERSAL DETECTION TECHNOLOGY AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2007


The option was valued at $661,484 using the Black Scholes model for American
Options, with volatility of 174% and risk-free interest rate of 4.65%. The
market price on the day of grant was $0.007. The Company recognized $661,484 as
expense during the first quarter of 2007.

NOTE 7 - RELATED PARTY TRANSACTIONS

During the three months ended March 31, 2007, the Company's president and CEO
loaned the Company a total of $21,000 with interest rates of 12%-12.5% under
various promissory note agreements. All notes have been repaid. The CEO has
elected to forgo interest payments on the notes due to the short-term payback
period.

NOTE 8 - SUBSEQUENT EVENTS

During April and May 2007, the Company issued an aggregate of 13,999,999 shares
of common stock to three employees for services rendered valued at approximately
$52,000.

During April and May 2007, the Company issued an aggregate of 47,439,992 shares
of common stock valued at approximately $196,804 in connection with services.

During May 2007, the Company issued an aggregate of 30,000,000 shares of common
stock in exchange for the cancellation of a promissory note with a principal
amount of $50,000.

On May 1, 2007, the Company issued a promissory note for $60,000 received from
an unrelated party. The note carries a 12.5% per annum interest rate and is due
on or before November 1, 2007.


11




ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

FORWARD-LOOKING STATEMENTS

THE INFORMATION IN THIS QUARTERLY REPORT ON FORM 10-QSB CONTAINS FORWARD-LOOKING
STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE SECURITIES ACT OF 1933, AS
AMENDED, AND SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
THESE FORWARD-LOOKING STATEMENTS INVOLVE RISKS AND UNCERTAINTIES, INCLUDING
STATEMENTS REGARDING OUR CAPITAL NEEDS, BUSINESS PLANS AND EXPECTATIONS. SUCH
FORWARD-LOOKING STATEMENTS INVOLVE RISKS AND UNCERTAINTIES REGARDING THE MARKET
PRICE OF GOLD, AVAILABILITY OF FUNDS, GOVERNMENT REGULATIONS, COMMON SHARE
PRICES, OPERATING COSTS, CAPITAL COSTS, OUTCOMES OF GOLD RECOVERY ACTIVITIES AND
OTHER FACTORS. FORWARD-LOOKING STATEMENTS ARE MADE, WITHOUT LIMITATION, IN
RELATION TO OPERATING PLANS, PROPERTY EXPLORATION AND GOLD RECOVERY ACTIVITIES,
AVAILABILITY OF FUNDS, ENVIRONMENTAL RECLAMATION, OPERATING COSTS AND PERMIT
ACQUISITION. ANY STATEMENTS CONTAINED HEREIN THAT ARE NOT STATEMENTS OF
HISTORICAL FACTS MAY BE DEEMED TO BE FORWARD-LOOKING STATEMENTS. IN SOME CASES,
YOU CAN IDENTIFY FORWARD-LOOKING STATEMENTS BY TERMINOLOGY SUCH AS "MAY",
"WILL", "SHOULD", "EXPECT", "PLAN", "INTEND", "ANTICIPATE", "BELIEVE",
"ESTIMATE", "PREDICT", "POTENTIAL" OR "CONTINUE", THE NEGATIVE OF SUCH TERMS OR
OTHER COMPARABLE TERMINOLOGY. ACTUAL EVENTS OR RESULTS MAY DIFFER MATERIALLY. IN
EVALUATING THESE STATEMENTS, YOU SHOULD CONSIDER VARIOUS FACTORS, INCLUDING THE
RISKS OUTLINED BELOW, AND, FROM TIME TO TIME, IN OTHER REPORTS WE FILE WITH THE
SEC. THESE FACTORS MAY CAUSE OUR ACTUAL RESULTS TO DIFFER MATERIALLY FROM ANY
FORWARD-LOOKING STATEMENT. WE DISCLAIM ANY OBLIGATION TO PUBLICLY UPDATE THESE
STATEMENTS, OR DISCLOSE ANY DIFFERENCE BETWEEN ITS ACTUAL RESULTS AND THOSE
REFLECTED IN THESE STATEMENTS. THE INFORMATION CONSTITUTES FORWARD-LOOKING
STATEMENTS WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF
1995. GIVEN THESE UNCERTAINTIES, READERS ARE CAUTIONED NOT TO PLACE UNDUE
RELIANCE ON SUCH FORWARD-LOOKING STATEMENTS.

OVERVIEW

We are engaged in the research and development of bio-terrorism detection
devices. Our strategy is to identify qualified strategic partners with whom to
collaborate in order to develop commercially viable bio-terrorism detection
devices. Consistent with this strategy, we integrated our proprietary bacterial
spore detection technology into our existing aerosol monitoring system,
resulting in a product named BSM-2000. BSM-2000 is designed to provide
continuous unattended monitoring of airborne bacterial spores in large public
places, with real-time automated alert functionality. The device is designed to
detect an increase in the concentration of bacterial spores, which is indicative
of a potential presence of Anthrax.

PLAN OF OPERATION

We plan to seek and find third parties interested in collaborating on further
research and development on BSM-2000. Such research shall be aimed at making
BSM-2000 more user-friendly, developing a less complicated interface and
software, designing a lighter casing, and some cosmetics. The ideal third party
collaborator would also assist us in marketing BSM-2000 more aggressively. There
is no guarantee that any such collaborators will be found and, if found,


12




that this strategy will be successful. The current version of BSM-2000 is fully
functional and available for sale. To date, we have sold two units to the
Government of the United Kingdom and we intend to develop a more wide-spread use
for BSM-2000 through our planned collaborative research, development, sales, and
marketing efforts.

We require approximately $4.2 million in the next 12 months to repay debt
obligations and execute our business plan. We do not anticipate that our cash on
hand is adequate to meet our operating expenses over the next 12 months. Also,
we do not believe we have adequate capital to repay all of our debt currently
due and becoming due in the next 12 months. We anticipate that our uses of
capital during the next 12 months principally will be for:

o administrative expenses, including salaries of officers and
other employees we plan to hire;

o repayment of debt;

o sales and marketing;

o product testing and manufacturing; and

o expenses of professionals, including accountants and
attorneys.

During the three months ended March 31, 2007 we spent an aggregate of $1,632,000
on selling, general and administrative expenses and marketing expenses. This
amount represents a 220% increase over the comparable year-ago period. The
increase is principally attributable to an expense recognized by the Company in
connection with the granting of stock options to its president and CEO.

Our working capital deficit at March 31, 2007, was $ 2,975,186. Our independent
auditors' report, dated March 9, 2007, includes an explanatory paragraph
relating to substantial doubt as to our ability to continue as a going concern,
due to our working capital deficit at December 31, 2006. We require
approximately $1.5 million to repay indebtedness in the next 12 months.

Management continues to take steps to address the Company's liquidity needs. In
the past, management has entered into agreements with some of our note holders
to amend the terms of our notes to provide for extended scheduled payment
arrangements. Management is engaged in discussions with each holder of debt that
is in default and continues to seek extensions with respect to our debt that is
past due. Management also may seek extensions with respect to our other debt as
it becomes due. In addition, management may endeavor to convert some portion of
the principal amount and interest on our debt into shares of common stock.

Historically, we have financed operations through private debt and equity
financings. In recent years, financial institutions have been unwilling to lend
to us and the cost of obtaining working capital from investors has been
expensive. We principally expect to raise funds through the sale of equity or
debt securities. During 2005, management spent the substantial majority of its
time negotiating contracts for the installation of the BSM-2000 in target
markets and developing its marketing and sales plan. These activities diverted
management from the time it otherwise would


13




spend negotiating sales of securities to raise capital. In addition, the more
recent price and volume volatility in the common stock has made it more
difficult for management to negotiate sales of its securities at a price it
believes to be fair to the Company. The Company actively continues to pursue
additional equity or debt financings, but cannot provide any assurance that it
will be successful. If we are unable to pay our debt as it becomes due and are
unable to obtain financing on terms acceptable to us, or at all, we will not be
able to accomplish any or all of our initiatives and will be forced to consider
steps that would protect our assets against our creditors.

OFF BALANCE SHEET ARRANGEMENTS

The Company does not have any off-balance sheet arrangements that have or are
reasonably likely to have a current or future effect on the Company's financial
condition, changes in financial condition, revenues or expenses, results of
operations, liquidity, capital expenditures or capital resources that are
material to investors.

ITEM 3. CONTROLS AND PROCEDURES

As required by SEC rules, we have evaluated the effectiveness of the design and
operation of our disclosure controls and procedures at the end of the period
covered by this report. The evaluation was carried out by our Chief Executive
Officer and Acting Principal Financial Officer (the "Certifying Officers").
Based upon this evaluation, the Certifying Officers have concluded that the
design and operation of our disclosure controls and procedures are effective.
Such disclosure controls and procedures are designed to ensure that material
information is made known to the Certifying Officers, particularly during the
period in which this report was prepared. The Certifying Officers have evaluated
the effectiveness of our disclosure controls and procedures as of the end of the
period covered by this report and believe that our disclosure controls and
procedures are effective based on the required evaluation. During the period
covered by this report, there were no changes in internal controls that
materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.

While management believes that our disclosure controls and procedures and our
internal control over financial reporting are effective, no system of controls
can prevent all error and all fraud. A control system, no matter how well
designed and operated, can provide only reasonable, not absolute, assurance that
the control system's objectives will be met. Further, the design of a control
system must reflect the fact that there are resource constraints, and the
benefits of controls must be considered relative to their costs. Because of the
inherent limitations in all control systems, no evaluation of controls can
provide absolute assurance that all control issues and instances of fraud, if
any, within our company have been detected. These inherent limitations include
the realities that judgments in decision-making can be faulty, and that
breakdowns can occur because of simple error or mistake. Controls can also be
circumvented by the individual acts of some persons, by collusion of two or more
people, or by management override of the controls. The design of any system of
controls is based in part upon certain assumptions about the likelihood of
future events, and there can be no assurance that any design will succeed in
achieving its stated goals under all potential future conditions. Over time,
controls may become inadequate because of changes in conditions or deterioration
in the degree of compliance with its policies or procedures. Because of the
inherent limitations in a cost-effective control system, misstatements due to
error or fraud may occur and not be detected.


14




PART II
OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

There are no reportable events to disclose hereunder.

Except as previously disclosed with the Commission, the Company is not a party
to any other pending legal proceedings, other than routine litigation deemed
incidental to our business.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

During the first quarter of fiscal 2007, we issued the following securities,
which were not registered under the Securities Act of 1933, as amended (the
"Securities Act"). The offer and sale of the following unregistered securities
is exempt from the registration requirements of the Securities Act, pursuant to
Section 4(2).

During the first three months ended March 31, 2007, we issued an aggregate of
60,000,000 shares of common stock to a vendor for $1,800,000 in cash
equivalents. The value of the stock on the day of issuance was $288,000.

On March 28, 2007, the Board of Directors approved the creation of the Series
A-1 Preferred Stock of the Company and the issuance of 150 shares of such stock
to Jacques Tizabi, the Company's President, CEO, and Acting CFO, in lieu of
$50,000 in accrued compensation.

On March 28, 2007, the Company granted to Mr. Tizabi an option to purchase
100,000,000 shares of the Company's Common Stock at an exercise price of $0.01
per share, for a term of five years. The option is fully vested and immediately
exercisable. The option was valued at $661,484 using the Black-Scholes model for
American Options, with volatility of 174% and risk-free interest rate of 4.65%.
The market price on the day of grant was $0.007. The Company recognized $661,484
as an expense during the first quarter of 2007.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

We have defaulted upon the following senior securities:

o One loan from three family members, each of whom is an
unaffiliated party, evidenced by four promissory notes in the
aggregate principal amounts of $100,000, $50,000, $50,000, and
$100,000, each due June 24, 2001 with interest rates ranging
from 11% to 12%. We entered into a settlement agreement in the
third quarter of 2004 with each of these parties. Pursuant to
this agreement, at June 30, 2005, we were required to pay an
additional $80,000 as full payment of our obligations. We did
not make scheduled payments and are in default of these notes.


15




o One loan from an unaffiliated party in the aggregate principal
amount of $195,000 with interest at a rate of 9% per annum.
Pursuant to a letter agreement dated as of August 10, 2004, we
entered into a settlement with this party and agreed to pay a
total of $261,000 pursuant to a scheduled payment plan through
July 2005. Additionally, the Company, in September 2004,
issued 206,250 shares of common stock upon the conversion of
unpaid interest in the aggregate amount of $33,000. At March
31, 2007, there was $161,000 principal amount remaining on
this note. We did not make our scheduled payment under this
note and are in default. As of March 31, 2007 we owed $39,528
in interest on this note.

o One loan from an unaffiliated party in the aggregate principal
amount of $98,500, due July 31, 2005, with interest at the
rate of 9% per annum. Pursuant to a letter agreement dated
August 10, 2004, between us and this third party, we agreed to
pay a total of $130,800 pursuant to a scheduled payment plan
through July 2005. At March 31, 2007 there was $ 74,500
principal amount remaining on this note. We did not make our
scheduled payments under this note and are in default. As of
March 31, 2007 we owed $23,391 in interest on this note.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

None.

ITEM 5. OTHER INFORMATION.

None.

ITEM 6. EXHIBITS.

EXHIBIT LIST

EXHIBIT
NUMBER DESCRIPTION
------------- --------------------------------------------------------------
Exhibit 3.1 Articles of Incorporation. (1)

Exhibit 3.2 Certificate of Amendment to Articles of Incorporation. (1)

Exhibit 3.3 Certificate of Amendment to Articles of Incorporation. (1)

Exhibit 3.4 Amended and Restated Bylaws. (2)

Exhibit 4.1 Certificate of Determination of Preferences of Preferred
Shares. (3)

Exhibit 4.2 Amended and Restated 2003 Stock Incentive Plan. (4)

Exhibit 4.3 2006 Stock Compensation Plan. (5)

Exhibit 4.4 Consultant Stock Plan. (6)

Exhibit 4.5 2006-II Consultant Stock Plan. (7)

Exhibit 10.1 Employment Agreement by and between the Company and Jacques
Tizabi dated September 25, 2001. (8)


16




Exhibit 10.2 Amendment to Employment Agreement of Jacques Tizabi, dated
August 23, 2004. (9)

Exhibit 10.3 Technology Affiliates Agreement by and between the Company and
California Institute of Technology, dated August 6, 2002. (10)

Exhibit 10.4 Licensing Agreement by and between the Company and California
Institute of Technology, dated September 30, 2003. (11)

Exhibit 10.5 Agreement for Investment Banking and Advisory Services, by and
between the Company and Astor Capital, Inc., dated June 1,
2003. (12)

Exhibit 10.6 Amendment to Agreement for Investment Banking and Advisory
Services with Astor Capital, Inc. dated April 29, 2004. (13)

Exhibit 10.7 Amendment to Agreement for Investment Banking and Advisory
Services with Astor Capital, Inc. dated September 22, 2004.
(14)

Exhibit 10.8 Standard Form Office Lease, dated September 2003, between
Astor Capital, Inc. and CSDV, a Limited Partnership. (15)

Exhibit 10.9 Assumption of Lease Agreement, dated October 14, 2004, between
the Company and Astor Capital, Inc. (15)

Exhibit 10.10 Letter Agreement, dated August 10, 2004, between the Company
and IIG Equity Opportunities Fund Ltd. (16)

Exhibit 10.11 Letter Agreement, dated August 10, 2004, between the Company
and Target Growth Fund Ltd. (16)

Exhibit 10.12 Letter Agreement, dated September 21, 2004 between the Company
and JRT Holdings. (17)

Exhibit 10.13 Letter Agreement, dated October 1, 2004, between the Company
and Ali Moussavi. (18)

Exhibit 10.14 Letter of Engagement dated August 19, 2005, between Trilogy
Capital Partners, Inc. and the Company. (19)

Exhibit 10.15 Form of Stock Purchase Warrant. (20)

Exhibit 10.16 Stock Purchase Warrant issued to Trilogy Capital Partners.
(21)

Exhibit 10.17 Investment Agreement by and between the Company and European
Equity Group. (22)

Exhibit 10.18 Form of Consulting Agreement. (23)

Exhibit 10.19 Stock Agreement, dated January 18, 2007, by and between the
Company and Innovative Marketing, Inc. (24)

Exhibit 21.1 Subsidiaries. (25)

Exhibit 31.1 Certification pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002, filed herewith

Exhibit 32.1 Certification pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
filed herewith

(1) Incorporated herein by reference to Exhibit 3(a) to the Company's
Registration Statement on Form 10.

(2) Incorporated by reference to Exhibit 3.4 of the Company's Annual Report on
Form 10-KSB for the year ended December 31, 2001, as filed April 15, 2002.

(3) Incorporated by reference to Exhibit 3.5 of the Company's Annual Report on
Form 10-KSB for the year ended December 31, 2006, as filed April 14, 2007.


17




(4) Incorporated by reference to Exhibit 4.2 of the Company's Annual Report on
Form 10-KSB for the year ended December 31, 2004, as filed on March 31,
2005.

(5) Incorporated by reference to the Company's Form S-8 Registration Statement
as filed February 13, 2006.

(6) Incorporated by reference to the Company's Form S-8 Registration Statement
as filed June 30, 2006

(7) Incorporated by reference to the Company's Form S-8 Registration Statement
as filed November 22, 2006.

(8) Incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report
on Form 10-QSB for the Quarter Ended March 31, 2002, as filed May 20, 2002.

(9) Incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report
on Form 10-QSB for the Quarter Ended September 30, 2004, as filed November
22, 2004.

(10) Incorporated herein by reference to Exhibit 10.3 to the Company's Annual
Report on Form 10-KSB for the fiscal year ended December 31, 2002, as filed
April 15, 2003.

(11) Incorporated by reference to Exhibit 10.4 to the Company's Quarterly Report
on Form 10-QSB for the Quarter Ended September 30, 2003, as filed November
19, 2003.

(12) Incorporated by reference to Exhibit 10.5 of the Company's Annual Report on
Form 10-KSB for the year ended December 31, 2003, as filed March 31, 2004.

(13) Incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report
on Form 10-QSB for the Quarter Ended June 30, 2004, as filed August 23,
2004.

(14) Incorporated by reference to Exhibit 10.4 to the Company's Quarterly Report
on Form 10-QSB for the Quarter Ended September 30, 2004, as filed on
November 22, 2004

(15) Incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report
on Form 10-QSB for the Quarter Ended September 30, 2004, as filed November
22, 2004.

(16) Incorporated by reference to the Company's Registration Statement on Form
SB-2, File No. 333-117859, as filed on February 2, 2005.

(17) Incorporated by reference to the Company's Registration Statement on Form
SB-2, File No. 333-117859, as filed on February 2, 2005.

(18) Incorporated by reference to the Company's Registration Statement on Form
SB-2, File No. 333-117859, as filed on February 2, 2005.

(19) Incorporated by reference to the Company's Registration Statement on Form
SB-2, File No. 333-117859, as filed on February 2, 2005.

(20) Incorporated by reference to Exhibit 10.15 to the Company's Registration
Statement on Form SB-2, as filed on February 14, 2006.

(21) Incorporated by reference to Exhibit 10.16 to the Company's Registration
Statement on Form SB-2, as filed on February 14, 2006.

(22) Incorporated by reference to Exhibit 10.17 to the Company's Registration
Statement on Form SB-2, as filed on February 14, 2006.

(23) Incorporated by reference to Exhibit 10.18 to the Company's Registration
Statement on Form SB-2, as filed on February 14, 2006.

(24) Incorporated by reference to Exhibit 10.19 to the Company's Current Report
on Form 8-K, as filed on January 31, 2007. (25) Incorporated by reference
to Exhibit 21.1 of the Company's Annual Report on Form 10-KSB for the year
ended December 31, 2003, as filed on March 31, 2004.


18




SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.


Dated: May 18, 2007 UNIVERSAL DETECTION TECHNOLOGY

[miss29]

May 21, 2007 - 7:05 AM EDT

close Email this News Article
Your Name
Your Email
Friend's Name
Friend's Email
Receive Copy: yes

UDTT 0.0036 0.00

Today 5d 1m 3m 1y 5y 10y



Universal Detection's Patent for Bacterial Spore Detection Technology Allowed by the European Patent Office

Universal Detection Technology (www.udetection.com) (OTCBB: UDTT), a developer of early-warning monitoring technologies to protect people from bioterrorism and a provider of counter-terrorism training and solutions, today announced that claims filed at the European Patent Office for the core technology of the BSM-2000, bacterial spore monitor, were allowed. This allowance will lead to the protection of UDTT's technology in up to 37 European countries.

"The allowance of the patent reduces our concerns over patent infringement in Europe," said Amir Ettehadieh, Director of Research and Development of Universal Detection Technology. "Our first sale of the BSM-2000 system was to the Government of the U.K., and we now plan to launch a more aggressive marketing campaign in Europe," he added.

BSM-2000 is UDTT's line of real-time bacterial spore detectors co-developed by NASA's Jet Propulsion Laboratory (JPL). The device is used to monitor the air continuously and to sound an alarm if elevated levels of spores such as anthrax are detected. UDTT holds an international exclusive license to the detection technology deployed in BSM-2000.

To view the video clip, please go to: http://www.udetection.com/pressroom-video-NBC1006.htm.

For more information, please visit www.udetection.com or email us at [e-mail].

About the European Patent Office

The European Patent Office (EPO) provides a uniform application procedure for individual inventors and companies seeking patent protection in up to 37 European countries. It is the executive arm of the European Patent Organization.

About Universal Detection Technology

[opelmanta3]

Antwort auf Beitrag Nr.: 29.402.468 von miss29 am 21.05.07 13:13:32

oje wieder eine gute news...dann gehts heute bestimmt wieder 20% runter LOL

[miss29]

Antwort auf Beitrag Nr.: 29.404.025 von opelmanta3 am 21.05.07 15:10:33

Wenn der CEO seine 100 Mio. Aktien hat dann KABOOOOOOOM !

[miss29]

Antwort auf Beitrag Nr.: 29.404.376 von miss29 am 21.05.07 15:33:45

Heute wird aber viel gekauft

[miss29]

Antwort auf Beitrag Nr.: 29.404.389 von miss29 am 21.05.07 15:34:33

Und nur aus dem ASK

[opelmanta3]

Antwort auf Beitrag Nr.: 29.404.389 von miss29 am 21.05.07 15:34:33

ups schon wieder rot...LOL...und wie offensichtlich...mit 5% des bisherigen tagesvolumens alles runtergeballert...ich lass mich mal auf .34 bedienen...und der ask is so hohl wie eim schweizer käse....verdamme manipulation...

[miss29]

Antwort auf Beitrag Nr.: 29.404.594 von opelmanta3 am 21.05.07 15:46:52

verdamme manipulation

GENAU !

[miss29]

[opelmanta3]

LOL danke für die shares @ .0034

damit mach ich locker 200% diese woche

[miss29]

0,003$

[opelmanta3]

jaja wie gesagt....gute news = 20% runter..wie immer

[opelmanta3]

marketcap ist unter 1MIO ... zum totlachen

[miss29]

Antwort auf Beitrag Nr.: 29.408.572 von opelmanta3 am 21.05.07 20:06:31

Was kostet so ein UDTT Antrax-Set ?

[miss29]

Jetzt wird wieder aus dem ASK gekauft

[opelmanta3]

In the second quarter of 2006, we updated our price list for BSM-2000. In evaluating the market demand for our product, BSM-2000, we retained the services of outside consultants, Joseph Breen Associates. Our new set price for BSM-2000 is $109,000. We also constructed two separate customer accounts called National and Key accounts. A Key account represents small to medium customers and resellers of BSM-2000 who purchase or intend to purchase a minimum of 3 to 5 units of BSM-2000 annually. This category of customers receives a 10% discount from list prices. A National account represents medium to large customers and resellers of BSM-2000 who purchase or intend to purchase more than 5 units of BSM-2000 annually. This category of customers receives a 20% discount from list prices. As such Key account and National account customers can purchase BSM-2000 for $98,000 and $87,000 per unit respectively.


keina ahnung was die kits kosten ich schätze 200-400$ / Stück...das ist aber rewine spekulation...wie auch immer die kits sind nett aber das richtige geschäft machen die BSM geräte...und da brauchen wir wohl nochn paar verkäufe...

[opelmanta3]

-25% mit 5000 shares .0027 = 13,50 $

[miss29]

Antwort auf Beitrag Nr.: 29.409.166 von opelmanta3 am 21.05.07 20:51:50

All Time Low

[miss29]

RSI < 30

[opelmanta3]

ein intraday reversal mit grünem abschluß wäre sehr schon in der letzten stunde...grade nach diesem neuen low...ich glaube die chance stehen nicht sooooooooooooooo schlech....

[opelmanta3]

so jetzt gehts los.003x.0033...gleich sind wir schon wieder grün...und dann starten wir morgen die turnaround story.....yeeeeeehaaaaaaaaaaaaaaaaaaaa

[opelmanta3]

.0033x.0035

grüner kurs zum schluß und wir explodieren mogen...dann noch 2 3 BSM geräte vertickt und wir haben den perfect storm in the making....

[luckier]

Antwort auf Beitrag Nr.: 29.409.532 von opelmanta3 am 21.05.07 21:21:28

und ARCA endlich im bid

[miss29]

Antwort auf Beitrag Nr.: 29.410.144 von luckier am 21.05.07 21:57:15

Und im ASK

1.00$ 99900
Archipelago Trading Services, Inc.

OTCBB TRADING
312-442-7700
ARCA

[miss29]

May 22, 2007 - 7:05 AM EDT

close Email this News Article
Your Name
Your Email
Friend\'s Name
Friend\'s Email
Receive Copy: yes

UDTT 0.0035 0.00

Today 5d 1m 3m 1y 5y 10y



Universal Detection Technology Enters Into Distribution Agreement With Gulf Security Solutions for Marketing of Products in the Persian Gulf Region
UDTT Recently Sold 100 Test Kits to Firm
Universal Detection Technology (www.udetection.com) (OTCBB: UDTT), a developer of early-warning monitoring technologies to protect people from bioterrorism and a provider of counter-terrorism training and solutions, today announced that it has entered into a distribution agreement with Gulf Security Solutions (GSS), a leading distributor of security products and solutions in the United Arab Emirates and the Persian Gulf region. Through this agreement UDTT will market its Bio-warfare test kits, building security consulting, and its flagship product, the BSM-2000 airborne Anthrax monitor.

\"We are pleased to have a distribution partner in such a vital region of the world,\" said Jacques Tizabi, CEO of Universal Detection Technology. \"By GSS representing our products in trade shows in the region we will gain access to a large customer base with potential interest in our products,\" he added.

Universal Detection Technology has co-developed a real-time Anthrax detection system, called BSM-2000, with NASA\'s Jet Propulsion Laboratory. The technology was recently featured on NBC News. To view the video clip, please go to: http://www.udetection.com/pressroom-video-NBC1006.htm.

For more information, please visit www.udetection.com or email us at [e-mail].

About the Gulf Security Solutions

Gulf Security Solutions is a leading distributor of security and counter-terrorism products in the United Arab Emirates with offices in Dubai and Abu Dhabi. It was founded in 2000 by individuals with over 20 years of experience in the security and counter-terrorism fields.

About Universal Detection Technology

[opelmanta3]

wow....gute umsatze ...5 MIO shares in den ersten 10 minuten...weiter so

[opelmanta3]

.0035 ist weck und direkt ein schöne .0038 trade...
das sieht doch sehr gut aus heute....up on high volume !!!

jetzt müssen wir .0045 durchbrechen dann gehts auf mit grpßen schritten

[miss29]

Universal Detection Technology to Develop Portable Anthrax Detector


Universal Detection Technology (www.udetection.com) (OTCBB: UDTT), a developer of early-warning monitoring technologies to protect people from bioterrorism and a provider of counter-terrorism training and solutions today announced that it has initiated Research and Development efforts into production of a portable version of its Anthrax Detection device. The device, which will be battery operated, will be optimal for use in smaller facilities such as a mail room.

"The BSM-2000 was designed to continuously monitor a large facility or a buildings HVAC system; however, the new device will be handheld and used for shorter operating cycles," said Amir Ettehadieh, Director of Research and Development at Universal Detection Technology. "A prefect use will be in a mail room where an operator can monitor an incoming batch of mail for contamination," he added.

Universal Detection Technology has co-developed a real-time Anthrax detection system, called BSM-2000, with NASA's Jet Propulsion Laboratory. UDT recently received an allowance on its patent claims from the European Patent Office.

The technology was recently featured on NBC News. To view the video clip, please go to: http://www.udetection.com/pressroom-video-NBC1006.htm." target="_blank" rel="nofollow ugc noopener">http://www.udetection.com/pressroom-video-NBC1006.htm.

For more information, please visit www.udetection.com or email us at [e-mail].

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact:
Jacques Tizabi
310-248-3655
Email Contact





Source: Market Wire (May 24, 2007 - 8:01 AM EDT)

News by QuoteMedia
www.quotemedia.com

[miss29]

[miss29]

Schönes Volumen bis jetzt

[miss29]

UDTT =

KZ: 0,0001$ dann RS 200:1

AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED SHARES

The consenting stockholders have also adopted and approved an amendment to increase the number of the Company's authorized shares of Common Stock from Four Hundred Eighty Million (480,000,000) to Twenty Billion (20,000,000,000) shares (the "Authorized Share Amendment"). The Common Stock shall have no par value.

REVERSE STOCK SPLIT

MATERIAL TERMS OF THE REVERSE SPLIT

The consenting stockholders have approved a resolution giving the Board of Directors discretionary authority to amend the Company's Certificate of Incorporation to effect a two-hundred-for-one (200:1) reverse stock split of the Common Stock of the Company (the "Reverse Split") at any time during the next twelve months or prior to the next annual meeting of stockholders, whichever occurs first. The Board had determined the split ratio based upon a review of the capital structure of the Company, including shares and convertible instruments outstanding, share price, general market conditions and the potential benefits from the Reverse Split.


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 14C INFORMATION

Information Statement Pursuant to Section 14(c) of the
Securities Exchange Act of 1934

Check the appropriate box:

|X| Preliminary Information Statement
|_| Confidential, for Use of the Commission Only (as permitted by Rule
14c-5(d)(2))
|_| Definitive Information Statement

UNIVERSAL DETECTION TECHNOLOGY
(Name of Registrant as Specified In Its Charter)

Payment of Filing Fee (Check the appropriate box)

|X| No fee required.

|_| Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.

1) Title of each class of securities to which transaction applies:


--------------------------------------------------------------------------------

2) Aggregate number of securities to which transaction applies:

--------------------------------------------------------------------------------


3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):

--------------------------------------------------------------------------------


4) Proposed maximum aggregate value of transaction:

--------------------------------------------------------------------------------


5) Total fee paid:

--------------------------------------------------------------------------------


|_| Fee paid previously with preliminary materials.
|_| Check box if any part of the fee is offset as provided by Exchange Act


Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

1) Amount Previously Paid:


--------------------------------------------------------------------------------

2) Form, Schedule or Registration Statement No.:

--------------------------------------------------------------------------------


3) Filing Party:

--------------------------------------------------------------------------------

4) Date Filed:

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

INFORMATION STATEMENT
OF
UNIVERSAL DETECTION TECHNOLOGY
9595 WILSHIRE BLVD., SUITE 700
BEVERLY HILLS, CALIFORNIA 90212

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US


A PROXY.

This Information Statement is first being furnished on or about June, ___, 2007 to the holders of record as of the close of business on May 11, 2007 of the common stock of Universal Detection Technology, a California Corporation (the "Company").

The Board of Directors has approved and a total of seven stockholders owning the equivalent of 292,626,162 shares of the Company's common stock and one stockholder owning 100% of the outstanding shares of the Company's Series A-1 Preferred Stock ("Series A-1 Preferred") that are entitled to vote on these actions as of May 11, 2007, have consented in writing to the actions described below. The shares of the Company's capital stock entitled to vote on these actions are hereinafter referred to as the "Voting Shares". Such approval and consent constitute the approval and consent of a majority of the total number of the Voting Shares and are sufficient under the California Corporations Code and the Company's By-Laws to approve the action. Accordingly, the action will not be submitted to the other stockholders of the Company for a vote, and this Information Statement is being furnished to stockholders to provide them with certain information concerning the action in accordance with Section 603(b) of the California Corporations Code and the requirements of the Securities Exchange Act of 1934 and the regulations promulgated thereunder, including Regulation 14C.

ACTION BY BOARD OF DIRECTORS AND
CONSENTING STOCKHOLDERS

GENERAL

The Company will pay all costs associated with the distribution of this Information Statement, including the costs of printing and mailing. The Company will reimburse brokerage firms and other custodians, nominees and fiduciaries for reasonable expenses incurred by them in sending this Information Statement to the beneficial owners of the Company's common and preferred stock.

The Company will only deliver one Information Statement to multiple security holders sharing an address unless the Company has received contrary instructions from one or more of the security holders. Upon written or oral request, the Company will promptly deliver a separate copy of this Information Statement and any future annual reports and information statements to any security holder at a shared address to which a single copy of this Information Statement was delivered, or deliver a single copy of this Information Statement and any future annual reports and information statements to any security holder or holders sharing an address to which multiple copies are now delivered. You should direct any such requests to the following address:

Universal Detection Technology
c/o Mr. Jacques Tizabi
9595 Wilshire Blvd., Suite 700
Beverly Hills, California 90212 Fax #: [phone]


--------------------------------------------------------------------------------

INFORMATION ON CONSENTING STOCKHOLDERS

Pursuant to the Company's Bylaws and the California Corporations Code, a vote by the holders of at least a majority of the outstanding shares of the Company entitled to vote (the "Voting Shares") is required to effect the action described herein. The Company's Articles of Incorporation does not authorize cumulative voting for these matters. As of the record date, the Company had the equivalent of 422,564,849 shares of common stock ( "Common Stock") issued and outstanding and 150 shares of Series A-1 Preferred with voting rights equal to 150 million shares of Common Stock issued and outstanding. Pursuant to Section 603(a) of the California Corporations Code, eight consenting stockholders voted in favor of the actions described herein in a joint written consent, dated May 11, 2007, attached hereto as EXHIBIT 1. Seven of the consenting stockholders are the record and beneficial owners of 292,626,162 shares of the Company's Common Stock, which represents approximately 24.9% of the total number of Voting Shares. The other consenting stockholder is the record and beneficial owner of 150 shares of Series A-1 Preferred or 100% of the issued and outstanding class of Series A-1 Preferred. Per the Certificate of Determination of Series A-1 Preferred, each holder of Series A-1 Preferred has the same voting rights as holders of shares of Common Stock; provided, however that each share of Series A-1 Preferred shall have 1,000,000 votes per share. The Common Stock and the Series A-1 Preferred shall vote together as a single class except as otherwise required by law, the Company's Articles of Incorporation or its Bylaws. Accordingly, the Series A-1 Preferred stockholder owns the voting rights to 150,000,000 or 26.2% of the total issued and outstanding Voting Shares of the Company on an as-converted basis. Combined, the eight consenting stockholders constitute 51.1 % of the total issued and outstanding Voting Shares of the Company. No consideration was paid for the consents of the stockholders. The consenting stockholders' names, affiliation with the Company and beneficial holdings are as follows:

NAME AFFILIATION VOTING SHARES PERCENTAGE
Jacques Tizabi President, CEO, Acting 150,000,000 26.2%
CFO, Director
Innovative Marketing, Inc. Stockholder 60,000,000 10.5%
Silverline Partners Limited Stockholder 14,000,000 2.4%
Stellar Ventures Stockholder 15,000,000 2.6%
Erick Richardson Stockholder 16,663,380 2.9%
Nimish Patel Stockholder 6,962,782 1.2%
Julius Investments Stockholder 30,150,500 5.3%

TOTAL 51.1%




INTEREST OF CERTAIN PERSONS IN OR OPPOSITION TO MATTERS TO BE ACTED UPON

None.

PROPOSALS BY SECURITY HOLDERS

None.

DISSENTERS' RIGHT OF APPRAISAL

None.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth information as of May 11, 2007 with respect to the beneficial ownership of the outstanding shares of Company's capital stock by
(i) each person known by Registrant who will beneficially own five percent (5%) or more of the outstanding shares; (ii) the officers and directors of the Company; and (iii) all the aforementioned officers and directors as a group.


--------------------------------------------------------------------------------

Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission and generally includes voting or investment power with respect to securities. Shares of Common Stock subject to options, warrants or convertible securities exercisable or convertible within 60 days of May 11, 2007 are deemed outstanding for computing the percentage of the person or entity holding such options, warrants or convertible securities but are not deemed outstanding for computing the percentage of any other person, and is based on 422,564,849 shares of Common Stock issued and outstanding on a fully diluted basis, as of May 11, 2007.

----------------------------------------------------------------------------------------------------------------
NUMBER OF SHARES NUMBER OF SHARES
OF COMMON STOCK OF PREFERRED STOCK
NAME OF BENEFICIAL OWNER, BENEFICIALLY PERCENT OF BENEFICIALLY PERCENT OF
TITLE AND ADDRESS+ OWNED (1) CLASS (1) OWNED (1) CLASS (1)
----------------------------------------------------------------------------------------------------------------
Jacques Tizabi, 107,979,700 (2) 25.6% 150 100%
President, CEO, Acting CFO,
Director
----------------------------------------------------------------------------------------------------------------
Ali Moussavi, 0 * 0 0
Vice President of Global
Strategy
----------------------------------------------------------------------------------------------------------------
Matin Emouna, 0 * 0 0
Director
----------------------------------------------------------------------------------------------------------------
Michael Collins, 0 * 0 0
Secretary and Director
----------------------------------------------------------------------------------------------------------------
Innovative Marketing 60,000,000 14.2% 0 0
2895 S. Federal Highway, Suite
B-1
Del Ray Beach, Florida 33483
----------------------------------------------------------------------------------------------------------------
Julius Investments 30,150,500 7.1% 0 0
91 Cheyne Walk
London SW10ODQ
UK
----------------------------------------------------------------------------------------------------------------
Directors and executive 107,979,700 (2) 25.6% 150 100%
officers as a group (4 persons)
----------------------------------------------------------------------------------------------------------------




+ The address of each person listed is 9595 Wilshire Blvd., Beverly Hills, CA 90212, unless otherwise indicated

(1) Under Rule 13d-3 under the Exchange Act, certain shares may be deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided. In computing the percentage ownership of any person, the amount of shares outstanding is deemed to include the amount of shares beneficially owned by that person (and only that person) by reason of these acquisition rights. As a result, the percentage of outstanding shares of any person as shown in this table does not necessarily reflect the person's actual ownership with respect to the number of shares of our Common Stock actually outstanding at May 11, 2007. As of May 11, 2007, we had 422,564,849 shares of Common Stock, no par value outstanding, and 150 shares of Series A-1 Preferred Stock, $.01 par value, outstanding.

(2) Includes 107,950,000 shares that may be acquired upon the exercise of fully vested options.


--------------------------------------------------------------------------------

CHANGE IN CONTROL

None.

NOTICE TO STOCKHOLDERS OF ACTION APPROVED BY CONSENTING STOCKHOLDERS

The following action was taken by written consent of the consenting stockholders:

ACTION 1
AMENDMENT TO THE CERTIFICATE OF INCORPORATION TO INCREASE THE AUTHORIZED SHARES

The consenting stockholders have also adopted and approved an amendment to increase the number of the Company's authorized shares of Common Stock from Four Hundred Eighty Million (480,000,000) to Twenty Billion (20,000,000,000) shares (the "Authorized Share Amendment"). The Common Stock shall have no par value.

The Authorized Share Amendment will be implemented by filing a Certificate of Amendment with the Secretary of State of the State of California. The text of the Authorized Share Amendment is attached to this Information Statement as EXHIBIT A to the resolutions approving the authorized share increase, which are attached to this Information Statement as EXHIBIT 1. Under Federal Securities laws, the Company cannot file the Certificate of Amendment until at least 20 days after the mailing of this Information Statement.

As of the record date, the authorized number of shares of the Company's Common Stock is 480,000,000, of which 422,564,849 shares are issued and outstanding. We believe that additional authorized shares are needed to provide the Company adequate flexibility to engage in future capital raising transactions, acquisitions or other transactions which might require the issuance of Common Stock. The future issuance of additional shares of Common Stock on other than a pro rata basis to existing stockholders will dilute the ownership of the current stockholders, as well as their proportionate voting rights.

We have no current plans to issue any of the additional authorized but unissued shares of Common Stock that will become available as a result of the filing of the Amendment.

Although this action is not intended to have any anti-takeover effect and is not part of any series of anti-takeover measures contained in any debt instruments or the Certificate of Incorporation or the Bylaws of the Company in effect on the date of this Information Statement, the Company's stockholders should note that the availability of additional authorized and unissued shares of Common Stock could make any attempt to gain control of the Company or the Board more difficult or time consuming and that the availability of additional authorized and unissued shares might make it more difficult to remove management. Although the Board currently has no intention of doing so, shares of Common Stock could be issued by the Board to dilute the percentage of Common Stock owned by a significant stockholder and increase the cost of, or the number of, voting shares necessary to acquire control of the Board or to meet the voting requirements imposed by California law with respect to a merger or other business combination involving the Company.


--------------------------------------------------------------------------------

ACTION 3
REVERSE STOCK SPLIT

MATERIAL TERMS OF THE REVERSE SPLIT

The consenting stockholders have approved a resolution giving the Board of Directors discretionary authority to amend the Company's Certificate of Incorporation to effect a two-hundred-for-one (200:1) reverse stock split of the Common Stock of the Company (the "Reverse Split") at any time during the next twelve months or prior to the next annual meeting of stockholders, whichever occurs first. The Board had determined the split ratio based upon a review of the capital structure of the Company, including shares and convertible instruments outstanding, share price, general market conditions and the potential benefits from the Reverse Split.

The amendment will be referred to in this Information Statement as the "Reverse Split Amendment". The proposed "form" of the Reverse Split Amendment is attached to this Information Statement as EXHIBIT B to the resolutions approving the Reverse Split, which resolutions attached to this Information Statement as EXHIBIT 1. The Reverse Split Amendment will become effective on the date it is filed with the Secretary of State of California, which date will be selected by the Board of Directors on or prior to the Company's next annual meeting of stockholders. However, the Board of Directors reserves the right to forego or postpone filing the Reverse Split Amendment if such action is determined not to be in the best interests of the Company and its stockholders. If the Reverse Split is not effected by the Board of Directors on or before the next annual meeting of stockholders, the authority to file the Reverse Split Amendment and effect the Reverse Split will lapse.

If the Reverse Split is effected by the Board of Directors, the Board of Directors will fix a record date for determining the shares subject to the Reverse Split. As of the date of this Information Statement, the Board of Directors has not fixed a record date for the Reverse Split.

The consenting stockholders believe that the Reverse Split will be in the best interest of the Company and its stockholders because the Company believes the Reverse Split will maximize stockholder value. Management believes that the Reverse Split is in the Company's best interest in that it may increase the trading price of its Common Stock. An increase in the price of the Common Stock could, in turn, generate greater investor interest in the Company, thereby enhancing the marketability of the Company's Common Stock to the financial community. The potential increases in the trading price and greater interest from the financial community could ultimately improve the trading liquidity of the Company's common shares.

The effect of the 200:1 Reverse Split would be to reduce the total number of shares of the Company's Common Stock from 422,564,849 to approximately 21,128,242 presently issued and outstanding. However, the Reverse Split will effect all of the holders of the Company's Common Stock uniformly and will not affect any stockholder's percentage ownership interest in the Company, except for insignificant changes that will result from the rounding of fractional shares.

The Reverse split will not have an effect on Series A-1 Preferred Stock or the Voting Power for holders thereof. After the reverse split, the current holder of Series A-1 Preferred, Jacques Tizabi, an officer and director of the Company, will possess 87.7% of the Voting Shares of the Company and will be the controlling stockholder of the Company. As of May 11, 2007, Mr. Tizabi held 26.2% of the outstanding Voting Shares.

If the Reverse Split is effected, it will take place without any action on the part of the holders of all classes of the Company's Common Stock and without regard to current certificates representing shares of all classes of the Company's Common Stock being physically surrendered for certificates representing the number of shares of all classes of the Company's Common Stock each stockholder is entitled to receive as a result of the Reverse Split. New certificates of the Company's Common Stock will not be issued.

No fractional shares will be issued in connection with the Reverse Split. Any fractional share will be rounded to the next whole share.


--------------------------------------------------------------------------------

We do not have any provisions in our Certificate of Incorporation, Bylaws, or employment or credit agreements to which we are party that have anti-takeover consequences. We do not currently have any plans to adopt anti-takeover provisions or enter into any arrangements or understandings that would have anti-takeover consequences. In certain circumstances, our management may issue additional shares to resist a third party takeover transaction, even if done at an above market premium and favored by a majority of independent shareholders. There are no adverse material consequences or any anti-takeover provisions in either our Certificate of Incorporation or Bylaws that would be triggered as a consequence of the Reverse Split. The Certificate of Incorporation or Bylaws do not address any consequence of the Reverse Split.

CERTAIN FEDERAL INCOME TAX CONSEQUENCES

The following summary of certain material federal income tax consequences of the Reverse Split does not purport to be a complete discussion of all of the possible federal income tax consequences and is included for general information only. Further, it does not address any state, local, foreign or other income tax consequences, nor does it address the tax consequences to stockholders that are subject to special tax rules, such as banks, insurance companies, regulated investment companies, personal holding companies, foreign entities, nonresident alien individuals, broker-dealers and tax-exempt entities. The discussion is based on the United States federal income tax laws as of the date of this Information Statement. Such laws are subject to change retroactively as well as prospectively. This summary also assumes that the shares of Common Stock are held as "capital assets," as defined in the Internal Revenue Code of 1986, as amended. The tax treatment of a stockholder may vary depending on the facts and circumstances of such stockholder.

EACH STOCKHOLDER IS URGED TO CONSULT WITH SUCH STOCKHOLDER'S TAX ADVISOR WITH RESPECT TO THE PARTICULAR TAX CONSEQUENCES OF THE REVERSE SPLIT.

No gain or loss should be recognized by a stockholder as a result of the Reverse Split; provided, however, any whole shares received in lieu of fractional shares may result in a taxable gain or loss. The aggregate tax basis of the shares received in the Reverse Split will be the same as the stockholder's aggregate tax basis in the shares exchanged. The stockholder's holding period for the shares received in the Reverse Split will include the period during which the stockholder held the shares surrendered as a result of the Reverse Split. The Company's views regarding the tax consequences of the Reverse Split are not binding upon the Internal Revenue Service or the courts, and there is no assurance that the Internal Revenue Service or the courts would accept the positions expressed above. The state and local tax consequences of the Reverse Split may vary significantly as to each stockholder, depending on the state in which such stockholder resides.

The reverse stock split will take effect upon the filing of an amendment to the Company's Articles of Incorporation with the Secretary of State of California. Under Federal Securities Laws, the Company cannot file the amendment until at least 20 days after mailing this Information Statement to our stockholders.


--------------------------------------------------------------------------------

EXHIBIT 1

WRITTEN CONSENT OF THE SHAREHOLDERS
OF
UNIVERSAL DETECTION CORPORATION
A CALIFORNIA CORPORATION

IN LIEU OF A SPECIAL MEETING OF SHAREHOLDERS

The undersigned, constituting the holders of more than fifty percent
(50%) of the outstanding common stock, no par value per shares ("Common Stock")
of Universal Detection Corporation, a California corporation (the "Corporation"), acting pursuant to the authority granted by Sections 603(a) of the General Corporation Law of the State of California, and the By-Laws of the Corporation, do hereby adopt the following resolutions by written consent as of May 16, 2007:

AMENDMENT OF THE CERTIFICATE OF INCORPORATION; REVERSE STOCK SPLIT;
INCREASE IN AUTHORIZED SHARES; WRITTEN CONSENT OF THE SHAREHOLDERS
APPROVING THE AMENDMENT OF THE CERTIFICATE OF INCORPORATION

WHEREAS, the Board of Directors of the Corporation (the "Board") has considered and unanimously approved that the Corporation effect a two-hundred-for-one reverse stock split of its shares of common stock, no par value, as the Board deems prudent and advisable, prior to the next Annual Meeting of Shareholders (the "Reverse Stock Split");

WHEREAS, the Board has considered and unanimously approved that the Corporation increase the number of shares of Common Stock the Corporation is authorized to issue from Four Hundred Eighty Million (480,000,000) to Twenty Billion (20,000,000,000) (the "Share Increase");

WHEREAS, the Board has considered and unanimously approved the proposed forms of Certificate of Amendment to the Articles of Incorporation substantially in the forms of that attached hereto as Exhibit I and Exhibit II; and

WHEREAS, the Board has determined that the Reverse Stock Split, Share Increase and form of Amendments are advisable and in the best interests of the Corporation and its shareholders.

NOW, THEREFORE, BE IT VOTED BY THE UNDERSIGNED, that the Board is hereby given the discretionary authority, prior to the next Annual Meeting of Shareholders, if the Board deems it in the best interest of the shareholders, to amend the Corporation's Articles of Incorporation to effect the Reverse Stock Split;


--------------------------------------------------------------------------------

BE IT FURTHER VOTED BY THE UNDERSIGNED, that the Share Increase be and hereby is ratified, adopted and approved by the undersigned;

BE IT FURTHER VOTED BY THE UNDERSIGNED, that the form of Amendments each be and hereby is ratified, adopted and approved by the undersigned; and

BE IT FURTHER VOTED BY THE UNDERSIGNED, that the officers of the Corporation are hereby authorized and approved to take all actions deemed necessary or desirable by them, or each acting alone, to cause the Corporation to effect the Reverse Stock Split and Share Increase and to duly file the Amendments is the State of California, with any changes or modifications the officer of the Corporation may deem necessary or desirable.

[SIGNATURE PAGE FOLLOWS]


--------------------------------------------------------------------------------

This Written Consent shall be added to the corporate records of the Corporation and made a part thereof, and the votes set forth below shall have the same force and effect as if adopted at a meeting duly noticed and held.

This Written Consent may be executed in counterparts and with facsimile signatures with the effect as if all parties hereto had executed the same document. All counterparts shall be construed together and shall constitute a single Written Consent as of the date of the final signature hereto.

THIS WRITTEN CONSENT MAY BE REVOKED BY THE UNDERSIGNED AT ANY TIME PRIOR TO THE TIME UPON WHICH WRITTEN CONSENTS OF THE NUMBER OF SHARES REQUIRED TO AUTHORIZE THE ABOVE PROPOSED ACTIONS HAVE BEEN FILED WITH THE SECRETARY OF THE CORPORATION.

By:
Name:
Common Stock Shareholder
Dated:
Number of Shares Voted:
CERTIFICATE OF VOTING CONTROL

I,_________________, the above executing Shareholder, do hereby represent, warrant and certify to the Corporation, that I have the sole and full right, power and authority, to exercise sole voting, investment and control over the shares of Common Stock of the Corporation so voted by me, acting alone, in the foregoing Written Consent.

By:
Name:
Common Stock Shareholder
Dated:
Number of Shares Voted:

--------------------------------------------------------------------------------

EXHIBIT A

CERTIFICATE OF AMENDENT OF
ARTICLES OF INCORPORATION OF
UNIVERSAL DETECTION CORPORATION

Jacques Tizabi and Michael Collins certify that:

1. They are the President and the Secretary, respectively, of UNIVERSAL DETECTION CORPORATION, a California corporation (the "Corporation").

2. Article IV of the Articles of Incorporation of the Corporation are amended to read in its entirety as follow:

"IV

GENERAL

This Corporation shall be authorized to issue a total of Twenty Billion Twenty Million (20,020,000,000) shares of all classes of stock. Of such total number of shares of stock, Twenty Billion (20,000,000,000) shares are authorized to be Common Stock, each of which shall have no par value ("Common Stock"), and Twenty Million (20,000,000) shares authorized to be Preferred Stock, each of which shares shall have a par value of $0.01 per shares ("Preferred Stock").

PREFERRED STOCK

Subject to the limitations prescribed by law, the Board of Directors is authorized to provide for the issuance of shares of the Preferred Stock authorized hereby in one or more series, and, by filing a certificate pursuant to the applicable law of the State of California, to establish from time to time the number of shares of each such series and the relative rights, preferences, powers, qualifications, limitations and restrictions thereof. With respect to any series of Preferred Stock that is established by the Board of Directors, the Board is authorized to increase or decrease (but not below the number of shares of such series then outstanding) the number of shares of such series subsequent t the issue of shares of that series. In case the number of shares of any series shall be so decreased, the shares constituting such decrease shall resume the status which they had prior to the adoption of the resolution originally fixing the number of shares of such series."


--------------------------------------------------------------------------------

3. The foregoing amendment to the Articles of Incorporation of the Corporation has been duly approved by the Corporation's Board of Directors.

4. The foregoing amendment of Articles of Incorporation has been duly approved by the required vote of shareholders in accordance with
Section 902, California Corporations Code. The total number of outstanding common shares of the corporation is 422,565,849 and there are 150 outstanding shares of Series A-1 Preferred Stock of the corporation. The number of shares voting in favor of the amendment equaled or exceeded the vote required. The percentage voted required was more than 50%.

DATE:________________________


--------------------------------------------------------------------------------

Jacques Tizabi, President

--------------------------------------------------------------------------------


Michael Collins, Secretary

--------------------------------------------------------------------------------

EXHIBIT B

CERTIFICATE OF AMENDENT OF
ARTICLES OF INCORPORATION OF
UNIVERSAL DETECTION CORPORATION

Jacques Tizabi and Michael Collins certify that:

1. They are the President and the Secretary, respectively, of UNIVERSAL DETECTION CORPORATION, a California corporation (the "Corporation").

2. Article IV of the Articles of Incorporation of the Corporation is amended to read in its entirety as follow:

"IV

GENERAL

This Corporation shall be authorized to issue a total of Twenty Billion Twenty Million (20,020,000,000) shares of all classes of stock. Of such total number of shares of stock, Twenty Billion (20,000,000,000) shares are authorized to be Common Stock, each of which shall have no par value ("Common Stock"), and Twenty Million (20,000,000) shares authorized to be Preferred Stock, each of which shares shall have a par value of $0.01 per shares ("Preferred Stock").

PREFERRED STOCK

Subject to the limitations prescribed by law, the Board of Directors is authorized to provide for the issuance of shares of the Preferred Stock authorized hereby in one or more series, and, by filing a certificate pursuant to the applicable law of the State of California, to establish from time to time the number of shares of each such series and the relative rights, preferences, powers, qualifications, limitations and restrictions thereof. With respect to any series of Preferred Stock that is established by the Board of Directors, the Board is authorized t increase or decrease (but not below the number of shares of such series then outstanding) the number of shares of such series subsequent t the issue of shares of that series. In case the number of shares of any series shall be so decreased, the shares constituting such decrease shall resume the status which they had prior to the adoption of the resolution originally fixing the number of shares of such series.

REVERSE STOCK SPLIT

Upon filing this Certificate of Amendment to the Articles of Incorporation of the Corporation (the "Split Effective Date"), each 200 shares of Common Stock, no par value per share, of the Corporation issued and outstanding or held as treasury shares immediately prior to the Split Effective Date (the "Old Common Stock") shall automatically without any action on part of the holder thereof, be reclassified and changed into one share of common stock, no par value per share, which the Corporation shall be authorized to issue immediately subsequent to


--------------------------------------------------------------------------------

the Split Effective Date (the "New Common Stock"). Each holder of a certificate or certificates which immediately prior to the Split Effective Date represented outstanding shares of Old Common Stock (the "Old Certificates") shall, from and after the Split Effective Date, be entitled to receive upon surrender of such Old Certificates to the Corporation's transfer agent for cancellation, a certificate or certificates (the "New Certificates") representing the shares of New Common Stock into which the shares of Old Common Stock formerly represented by such Old Certificates so surrendered are reclassified under the terms hereof. If any conversion of Old Common Stock hereunder would create a fractional share that is less than one-half of one percent of the total shares of Common Stock that Holder is entitled to receive, such fractional share shall be disregarded and the number of shares of Common Stock issuable upon such conversion, in the aggregate, shall be the nearest whole number of shares of Common Stock. If any such conversion would create a fractional share that is greater than one-half of one percent of the total shares of Common Stock that Holder is entitled to receive, then the Company shall pay that Holder in cash the fair value of the fractional share."

3. The foregoing amendment to the Articles of Incorporation of the Corporation has been duly approved by the Corporation's Board of Directors.

4. The foregoing amendment of Articles of Incorporation has been duly approved by the required vote of shareholders in accordance with
Section 902, California Corporations Code. The total number of outstanding common shares of the corporation is 422,565,849 and there are 150 outstanding shares of Series A-1 Preferred Stock of the corporation. The number of shares voting in favor of the amendment equaled or exceeded the vote required. The percentage voted required was more than 50%.

DATE:________________________


--------------------------------------------------------------------------------

Jacques Tizabi, President

--------------------------------------------------------------------------------


Michael Collins, Secretary

[miss29]

Antwort auf Beitrag Nr.: 29.279.076 von luckier am 12.05.07 10:25:03

Was geht heute ab ?

[Saftladen]

UNIVERSALabfragung TECH Universalabfragung Technologie stellt Dienstleistungsreseller-Programm her 5/31/2007 Firma stößt allgemein Reseller-Netz aus, um Verwendbarkeit der vorgerückten Bio-Abfragung und Sicherheit Lösungen zu verlängern LOS ANGELES, Ca, 31. Mai 2007 (MARKT-LEITUNG über COMTEX Nachrichten Netz) -- Universalabfragung Technologie (www.udetection.com) (OTCBB: UDTT), ein Entwickler der Frühwarnüberwachentechnologien, zum der Leute vor bioterrorism und des Versorgers des Gegenterrorismustrainings und -lösungen zu schützen, verkündeten heute die Produkteinführung des UDTT Dienstleistungsprogramms des Reseller (VAR). Das UDTT VAR Netz der in hohem Grade auserwählten allgemein Resellers verlängert erheblich die Verwendbarkeit UDTT Bio-Abfragung und Sicherheit der Produkte, der Hilfsprogramme und der Dienstleistungen auf Endbenutzer. Das UDTT VAR Programm erhöht die Zugänglichkeit des BSM-2000, beweglichen des Anthrax-Abfragung Systems und der Bio-Abfragung Installationssätze auf im ganzen Land bestehen und mögliche Kunden. „Da wir unsere Produktunterseite erweitert haben, die wir geschaut haben, um unsere bioterrorism Abfragung Technologien zu den Stadtbezirken und zu den lokalen Gesetzdurchführung- und Sicherheitsbeamten zu vermarkten,“ sagte Jacques Tizabi, CEO der Universalabfragung Technologie. „Netz VAR UDTTS wird erwartet, um Belichtung für Anthrax-Abfragung Installationssätze UDTTS zu erhöhen und autonome Anthraxabfragung Realzeitsysteme,“ fügte er hinzu. Universalabfragung Technologie zusammen entwickel ein Realzeitanthraxabfragung System, genannt BSM-2000, mit Antrieb-Labor Strahl der NASAs. UDTT leiten vor kurzem Forschung für Entwicklung eines beweglichen Anthrax-Abfragung Systems für Gebrauch in den Posträumen ein. Die Technologie wurde vor kurzem auf NBC Nachrichten gekennzeichnet. Um den videoclip anzusehen, bitte gehen: http://www.udetection.com/pressroom-video-NBC1006.htm. Zu mehr Information www.udetection.com oder email wir an [e-mail] bitte besuchen.

[opelmanta3]

Universal Detection Technology Enters Into Agreement With Gulf Security Solutions for Marketing of Portable Anthrax Detector in the Persian Gulf Region
Monday June 4, 7:01 am ET


LOS ANGELES, CA--(MARKET WIRE)--Jun 4, 2007 -- Universal Detection Technology (www.udetection.com) (OTC BB:UDTT.OB - News), a developer of early-warning monitoring technologies to protect people from bioterrorism and a provider of counter-terrorism training and solutions, today announced that it has expanded its distribution agreement with Gulf Security Solutions (GSS), a leading distributor of security products and solutions in the United Arab Emirates and the Persian Gulf region, to include UDTT\'s portable anthrax detectors. UDTT recently announced that it has initiated research and development efforts on production of a portable version of its anthrax detection devide.
\"We are excited about our distribution agreement with Gulf Secutiry Solutions and we anticipate the UAE to be a promising market for our portable anthrax detectors,\" said Jacques Tizabi, CEO of Universal Detection Technology.

Universal Detection Technology has co-developed a real-time Anthrax detection system, called BSM-2000, with NASA\'s Jet Propulsion Laboratory. The technology was recently featured on NBC News. To view the video clip, please go to: http://www.udetection.com/pressroom-video-NBC1006.htm." target="_blank" rel="nofollow ugc noopener">http://www.udetection.com/pressroom-video-NBC1006.htm.

For more information, please visit www.udetection.com or email us at [e-mail].

ADVERTISEMENT


About the Gulf Security Solutions

Gulf Security Solutions is a leading distributor of security and counter-terrorism products in the United Arab Emirates with offices in Dubai and Abu Dhabi. It was founded in 2000 by individuals with over 20 years of experience in the security and counter-terrorism fields.

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bioterror \'smoke\' detector that detects certain biohazard substances. For more information, please visit http://www.udetection.com.

[opelmanta3]

weeeeeeeeeeeeeeeeeeeeeeeeeeeeeee

[Saftladen]

[charlie01]

Press Release Source: Universal Detection Technology

Universal Detection Technology Receives Order From Foot Locker, Inc. for Bioterrorism Detection Kits
Thursday June 28, 7:00 am ET
Kits Used for Detection of Anthrax, Ricin Toxin, Botulinum Toxin, Plague, and SEBs to be Used for Security At Foot Locker's Main Distribution Warehouse

LOS ANGELES, June 28, 2007 (PRIME NEWSWIRE) -- Universal Detection Technology (http://www.udetection.com) (OTC BB:UDTT.OB - News), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that is has received a purchase order for its bioterrorism detection kits from Foot Locker, Inc. to be deployed at a Footlocker warehouse.

ADVERTISEMENT
The purchase order from Foot Locker is a major milestone for the company and it's a result of UDTT's new efforts to market its security solutions to civilian and corporate users. The kits are to be used at Foot Locker's Main Distribution Warehouse and will detect five bioterrorism agents: anthrax, ricin, botulinum toxin, plague, and SEBs.

UDTT's counter terrorism and security solutions, including Company's flagship real time anthrax detector (BSM-2000), have applications for government agencies, defense contractors, security companies, postal facilities, warehouses, and the like.

``We are extremely pleased to have received this order. We have been increasing our marketing efforts to expand our reach beyond government and defense users of our solutions to civilian and corporate customers and the purchase order from Foot Locker is an indication of the demand among corporations and non-defense related businesses for our technologies and solutions,'' said Jacques Tizabi, UDTT's Chairman and CEO.

A recent video featuring the company can be viewed by clicking here or going to: http://www.udetection.com/pressroom-video-NBC1006.htm.

For more information please visit http://www.udetection.com or

Email us at [e-mail].

About Foot Locker, Inc.

Foot Locker is a leading retailer of athletic footwear and apparel. Headquartered in New York City, it operates more than 400 stores in 20 countries in North America, Europe, and Australia under the brand names Foot Locker, Footaction, Lady Foot Locker, Kids Foot Locker, and Champs Sports.

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bio-terror 'smoke' detector that detects certain bio hazard substances. For more information, please visit http://www.udetection.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.


Contact:

Universal Detection Technology
Jacques Tizabi
310-248-3655
[e-mail]

Source: Universal Detection Technology

[a-h-kulthaus]

Hier ist heute nun die Party

[Saftladen]

[stocknewbie]

Totgesagte leben länger ...

[Saftladen]

Universalabfragung Technologie empfängt ersten Kaufauftrag für seine Strahlung Abfragung Vorrichtungen
9/4/2007

Kaufauftrag empfangen für Röntgenstrahl-, Beta- und Gammaelektronisches Dosimeter

LOS ANGELES, Ca, 4. Sep. 2007 (MARKT-LEITUNG über COMTEX Nachrichten Netz) --
Universalabfragung Technologie (www.udetection.com) (OTCBB: UDTT), ein Entwickler und ein Marketingspezialist der Frühwarnüberwachentechnologien, zum der Leute vor bioterrorism zu schützen, heute verkündet, daß es seinen ersten Kaufauftrag für eins der Produkte innerhalb der zusätzlichen Linie der Firma eben der radiologischen Abfragung Systeme empfangen hat. Der Kaufauftrag ist für ein Dosimeter, das simultanem Maß von x, von Gamma und von Betastrahlungen eingeweiht wird. Er ist klein schroff, ergonomisch, kompakt, und stimmt mit internationalen Standards überein.

„Wir werden extrem aufgeregt, unseren ersten Kaufauftrag für eine unserer Strahlung Abfragung Vorrichtungen erhalten zu haben. Dieses ist ein Teil unserer fortwährenden Strategie, zum ein Versorger der hochwertigen Abfragung Systeme zu werden, der zahlreiche Waffen der Massenzerstörung bedeckt. Vorher waren wir hauptsächlich auf die Abfragung der biologischen Waffen gerichtet worden und dieses ist ein HauptBeutezug für uns in den Strahlung Abfragung Markt,“ sagte Jacques Tizabi, Generaldirektor UDTTS.

Der Kaufauftrag war von den Florida-based internationalen Sicherheit Unternehmen Sicherheit Lösungen.

Ein neuer Bildschirm, der die Firma kennzeichnet, kann angesehen werden, indem man hier klickt oder geht: http://www.udetection.com/pressroom-video-NBC1006.htm." target="_blank" rel="nofollow ugc noopener">http://www.udetection.com/pressroom-video-NBC1006.htm.

Zu mehr Information www.udetection.com bitte besuchen oder

Email wir an [e-mail].

Über Universalabfragung Technologie

Universalabfragung Technologie ist ein Entwickler der überwachung von Technologien, einschließlich bioterrorism Abfragung Vorrichtungen. Die Firma, eigenständig und mit Entwicklung Partnern, wird in Position gebracht, um auf den Gelegenheiten gross zu schreiben, die auf Heimat-Sicherheit bezogen werden. Z.B. hat die Firma, in Zusammenarbeit mit der NASA, einen Bio-terror „Rauch“ Detektor entwickelt, der bestimmte biohazard Substanzen ermittelt. Zu mehr Information http://www.udetection.com bitte besuchen.